Enviracor J-5 (Canada)

Manufacturer: Zoetis

Escherichia Coli Bacterin J-5 Strain

For veterinary use only

Enviracor^® J-5 Bacterin is recommended for use in healthy dairy cattle as an aid in the control of clinical signs associated with E. coli mastitis. For effective mastitis control this product should be used in conjunction with acceptable good management practices.

Directions For Use

Shake well. Three doses are required. Administer each 5-mL dose subcutaneously in the neck, using aseptic technique. Vaccinate cows or heifers at both 7 and 8 months of gestation followed by the third dose within two weeks postpartum. Use entire contents when first opened.

Precautions

Store at 2°-7° C. Do not freeze. No milk discard is required. Do not vaccinate within 60 days before slaughter. Local swelling occasionally occurs and may persist at the injection site. In case of anaphylactoid reactions, epinephrine should be administered immediately.

^®Registered trade-mark of Pharmacia & Upjohn Company LLC; Pfizer Canada Inc. licensee.

For technical assistance 1-800-461-0917.

U.S. Vet Licence No. 357

Manufactured by: PHL Associates, Inc., Davis, CA USA 95616

Distributed in Canada by: Pfizer Animal Health, Pfizer Canada Inc., Kirkland QC H9J 2M5

20 doses

100 mL

1624013 804 822 000

NAC No.: 11982843